Wednesday, June 3, 2020

Gilead#39;s remdesivir could see $7 billion in annual sales on stockpiling boost: Analyst

Gilead#39;s remdesivir could see $7 billion in annual sales on stockpiling boost: Analyst The US drugmaker is yet to set a price for the drug that is currently being administered intravenously in hospitals.

from Moneycontrol Business News https://ift.tt/2U7W6rX

No comments:

Post a Comment

D-St surges 1% on reports govt to cut tax on foreign bond bets

Indian stock markets surged on Thursday. The Nifty and Sensex saw significant gains. This rise was driven by reports of a potential tax cut ...